Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
© 2019 Leelawattanachai et al. Limited information exists regarding the optimal dose of posaconazole delayedrelease tablet for the treatment of invasive mold infection. Here, we report the case of a previously healthy 44-year-old Thai man who developed coexisting invasive pulmonary aspergillosis and...
Saved in:
Main Authors: | Pannee Leelawattanachai, Preecha Montakantikul, Wichit Nosoongnoen, Methee Chayakulkeeree |
---|---|
Other Authors: | Vajira Hospital |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/50540 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Invasive mold infection in kidney transplant recipients: Observation of early-onset mucormycosis
by: M. Chayakulkeeree, et al.
Published: (2018) -
Pharmacokinetic and pharmacodynamic approach in adult critically-ill patients treated with standard dose of vancomycin for MRSA infection
by: Eko Setiawan, et al.
Published: (2019) -
Characteristics and Outcomes of Patients with Invasive Pulmonary Aspergillosis and Respiratory Tract Aspergillus Colonization from a Tertiary University Hospital in Thailand
by: Pannathat Soontrapa, et al.
Published: (2022) -
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
by: Sophida Boonsathorn, et al.
Published: (2020) -
A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring
by: Pitchaya Dilokpattanamongkol, et al.
Published: (2019)